Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-15 Sale |
2024-05-17 4:05 pm |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $3.75 | $131,250 | 0 (Direct) |
View |
2023-05-11 Sale |
2023-05-11 9:01 pm |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $3 | $105,000 | 0 (Direct) |
View |
2023-04-03 Sale |
2023-04-04 7:59 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
8,500 | $97.09 | $825,265 | 28,950 (Direct) |
View |
2022-04-14 Sale |
2022-04-18 8:22 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $83.66 | $355,555 | 23,970 (Direct) |
View |
2022-01-14 Sale |
2022-01-19 6:34 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $87.61 | $372,343 | 28,220 (Direct) |
View |
2021-04-15 Sale |
2021-04-19 4:09 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $76.9 | $576,750 | 18,850 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 6:43 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $87.41 | $655,575 | 26,350 (Direct) |
View |
2020-06-05 Sale |
2020-06-09 6:04 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,430 | $107.46 | $476,048 | 18,850 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-15 Exercise |
2024-05-17 4:05 pm |
N/A N/A |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $1.94 | 0 (Direct) |
View |
2024-05-15 Exercise |
2024-05-17 4:05 pm |
N/A 2024-05-20 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $0 | 0 (Direct) |
View |
2024-05-09 Option Award |
2024-05-10 4:05 pm |
N/A 2034-05-08 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
180,000 | $0 | 180,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 7:32 pm |
N/A 2033-05-30 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
125,000 | $0 | 125,000 (Direct) |
View |
2023-05-23 Option Award |
2023-05-24 6:27 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,190 | $0 | 33,140 (Direct) |
View |
2023-05-11 Exercise |
2023-05-11 9:01 pm |
N/A N/A |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $1.1 | 0 (Direct) |
View |
2023-05-11 Exercise |
2023-05-11 9:01 pm |
N/A 2023-05-22 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
35,000 | $0 | 0 (Direct) |
View |
2023-04-03 Exercise |
2023-04-04 7:59 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
8,500 | $67.81 | 28,950 (Direct) |
View |
2023-04-03 Exercise |
2023-04-04 7:59 pm |
2013-11-15 2023-05-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
8,500 | $0 | 28,950 (Direct) |
View |
2022-06-07 Option Award |
2022-06-09 9:15 pm |
N/A 2032-06-06 |
Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director |
43,000 | $0 | 43,000 (Direct) |
View |
2022-05-24 Option Award |
2022-05-26 9:15 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,980 | $0 | 28,950 (Direct) |
View |
2022-05-10 Option Award |
2022-05-11 6:16 pm |
N/A 2032-05-09 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
125,000 | $0 | 125,000 (Direct) |
View |
2022-04-14 Exercise |
2022-04-18 8:22 pm |
2012-11-08 2022-05-07 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $0 | 23,970 (Direct) |
View |
2022-04-14 Exercise |
2022-04-18 8:22 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $37.46 | 23,970 (Direct) |
View |
2022-01-14 Exercise |
2022-01-19 6:34 pm |
2012-11-08 2022-05-07 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $0 | 28,220 (Direct) |
View |
2022-01-14 Exercise |
2022-01-19 6:34 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,250 | $37.46 | 28,220 (Direct) |
View |
2021-06-08 Option Award |
2021-06-09 5:23 pm |
N/A 2031-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director |
40,000 | $0 | 40,000 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 7:02 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
5,120 | $0 | 23,970 (Direct) |
View |
2021-05-11 Option Award |
2021-05-13 9:16 pm |
N/A 2031-05-10 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
83,000 | $0 | 83,000 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 4:09 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $0 | 18,850 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 4:09 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $26.49 | 18,850 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:43 pm |
2011-11-12 2021-05-11 |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $0 | 26,350 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:43 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
7,500 | $26.49 | 26,350 (Direct) |
View |
2021-01-11 Option Award |
2021-01-13 4:25 pm |
N/A 2031-01-11 |
Coherus BioSciences Inc. | CHRS | LAWLIS V BRYAN Director |
20,000 | $0 | 20,000 (Direct) |
View |
2020-06-08 Option Award |
2020-06-10 4:24 pm |
N/A 2030-06-07 |
Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director |
28,100 | $0 | 28,100 (Direct) |
View |
2020-06-05 Option Award |
2020-06-09 6:12 pm |
N/A 2030-06-04 |
GERON CORP | GERN | LAWLIS V BRYAN Director |
83,000 | $0 | 83,000 (Direct) |
View |
2020-05-27 Option Award |
2020-05-29 5:38 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director |
4,300 | $0 | 23,280 (Direct) |
View |